DRUG METABOLISM: SUSCEPTIBILITY TO DELAYED TERATOGENESIS
DRUG METABOLISM: SUSCEPTIBILITY TO DELAYED TERATOGENESIS
批准号:
2197298
负责人:
BERNARD Harris SHAPIRO
金额:
$28.81万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1997-08-31
关键词:
androgen receptor cytochrome P450 drug metabolism embryo /fetus toxicology enzyme activity glutamates hormone receptor hormone regulation /control mechanism isozymes laboratory rat messenger RNA newborn animals northern blottings oxidoreductase phenobarbital phenytoin postpartum posttranslational modifications sweetening agents teratogens western blottings
中文摘要
在过去的二十年里,
孕妇吸毒。 虽然这些药物可能
治疗,或至少无毒的母亲,他们可以产生
对未出生的孩子造成无法弥补的损害。 事实证明,药物
在怀孕期间服用可能会作为致畸剂产生结构
胎儿畸形 许多药物也可以产生更微妙的
胎儿的生化和生理致畸缺陷。 而
这些可能是出生时不明显的“延迟”缺陷,
在儿童时期,它们是长期和永久性的缺陷。 作为
大多数药物很容易通过胎盘“屏障”,
以及乳腺上皮细胞进入乳汁,
仍然容易受到母体给药的致畸作用的影响
从受孕、胎儿发育、分娩和
护理学 正如产妇吸毒会威胁到婴儿的健康一样,
未出生的孩子,一个更阴险的危险可能会导致从
无意中暴露的perinate到一个“海”的弥漫
环境化学品。 我们的空气、水和空气中的许多化学物质,
食物供应会导致畸形,就像某些药物一样,
他们提出,它们也可能产生更微妙的生化缺陷。 在
支持我们的假设,我们发现围产期暴露于
苯妥英钠、苯巴比妥、苯妥英钠的治疗或饮食水平
谷氨酸盐(MSG)和天冬氨酸盐(MSA)都可以产生潜在的,
但肝单加氧酶系统永久性缺陷。 在一些情况下
缺陷是“无声的”,只有当系统被
用诱导剂攻击 在未来的研究中,我们建议
研究两个基本问题。1)致畸剂是如何诱导
暴露时的缺陷?2)潜在的缺陷是如何表现的
在成年期?我们计划通过以下方式来研究这些问题:a)确定
P450及其mRNA的易感形式,B)鉴定P450及其mRNA中的缺陷,
诱导机制,c)研究内源性激素在
单加氧酶缺陷的诱导和表达,和d)
研究荷尔蒙逆转异常的能力。
英文摘要
During the past two decades there has been a dramatic increase in the
consumption of drugs by pregnant women. While these drugs may be
therapeutic, or at least nontoxic to the mother, they could produce
irreparable damage to the unborn child. It has been shown that drugs
taken during pregnancy may act as teratogens producing structural
malformations in the fetus. Many drugs can also produce more subtle
biochemical and physiological teratogenic defects in the fetus. While
these may be "delayed" defects that are not apparent at birth or even
during childhood, they are both longterm and permanent defects. As a
preponderance of drugs easily pass through the placental "barrier" as
well as the mammary epithelium into the milk, the developing mammal
remains susceptible to the teratogenic effects of maternally administered
drugs from conception, through fetal development, parturition and during
nursing. Just as maternal drug consumption can threaten the health of
the unborn child, a far more insidious danger may result from the
inadvertent exposure of the perinate to a "sea" of pervasive
environmental chemicals. Many of the chemicals in our air, water and
food supply can cause malformations, and like certain drugs, we have
proposed that they may also produce more subtle biochemical defects. In
support of our hypothesis, we have found that peripartum exposure to
therapeutic or dietary levels of phenytoin, phenobarbital, monosodium
glutamate (MSG) and monosodium aspartate (MSA) can all produce latent,
but permanent defects in the hepatic monooxygenase system. In some cases
the defects are "silent", and are only expressed when the system is
challenged with an inducing agent. In future studies we propose to
examine two fundamental questions. 1) How do the teratogens induce their
defects at the time of exposure? 2) How are the latent defects expressed
in adulthood? We plan to examine these questions by a) determining the
susceptible forms of P450 and their mRNAs, b) identifying the defects in
the induction mechanisms, c) studying the role of endogenous hormones in
the induction and expression of the monooxygenase defects, and d)
investigating the ability of hormones to reverse the abnormalities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
-
批准号:8686904
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2010
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
-
批准号:8469068
-
项目类别:
-
资助金额:$30.25万
-
财政年份:2010
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
-
批准号:7872047
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2010
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
-
批准号:8089388
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2010
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Hormonal Imprinting Predetermines Developmental Expression of Cytochrome P450s
-
批准号:8301001
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2010
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:3305188
-
项目类别:
-
资助金额:$27.66万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:3305189
-
项目类别:
-
资助金额:$24.9万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Endogenous Regulators of Drug Metabolism
-
批准号:6469991
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:2183380
-
项目类别:
-
资助金额:$25.99万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:2022456
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:2749881
-
项目类别:
-
资助金额:$27.64万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:2183381
-
项目类别:
-
资助金额:$27.09万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Endogenous Regulators of Drug Metabolism
-
批准号:6623741
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Endogenous Regulators of Drug Metabolism
-
批准号:6767608
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Endogenous Regulators of Drug Metabolism
-
批准号:6934531
-
项目类别:
-
资助金额:$33.68万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:6018835
-
项目类别:
-
资助金额:$28.39万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
ENDOGENOUS REGULATORS OF DRUG METABOLISM
-
批准号:6179345
-
项目类别:
-
资助金额:$29.24万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
Enodgenous Regulators of Drug Metabolism
-
批准号:6369579
-
项目类别:
-
资助金额:$31.7万
-
财政年份:1992
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
DELAYED TERATOGENIC EXPRESSION OF ANTICONVULSANTS
-
批准号:3399320
-
项目类别:
-
资助金额:$10.35万
-
财政年份:1984
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
DELAYED TERATOGENIC EXPRESSION OF ANTICONVULSANTS
-
批准号:3399319
-
项目类别:
-
资助金额:$10.29万
-
财政年份:1984
-
负责人:BERNARD Harris SHAPIRO
-
依托单位:
海外基金